Delivery Order SPE2DB22D2211-SPE2DB25FSFET
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,057.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (10 count) on October 16, 2025, with completion targeted for November 6, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $4,115.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-competitive delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,115.60 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (10-count units). This firm fixed-price delivery order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, represents a non-competitive procurement under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Testopel 75 mg pellets valued at $10,289.00. This delivery order, issued on August 25, 2025, represents a firm fixed price contract with performance expected to conclude by September 16, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $4,115.58 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $8.2K. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.80 to AmerisourceBergen Drug Corp for Testopel 75 mg pellets on June 11, 2025, with a completion date of July 3, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Testopel is a testosterone replacement therapy product used in hormone treatment applications within military and federal healthcare...
- The Defense Logistics Agency awarded a $4,115.60 delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (10 count) with an ultimate completion date of August 14, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,346.74 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (100-count units) with a completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- AmerisourceBergen Drug Corp received a delivery order award valued at $4,115.58 from the Defense Logistics Agency Medical Supply Chain on July 17, 2025, for the supply of Testopel 75 mg pellets (100-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive award executed under an existing contract vehicle. The work will be performed at the contractor's corporate office location in Conshohocken,...